Ursolic Acid, A Pentacyclic Triterpene From Ochrosia Elliptica Labill Leaves And Its Role In The Management Of Polycystic Ovary Syndrome

    March 2026 in “ Inflammopharmacology ”
    Shimaa R. Emam, Mohamed Abbas Ibrahim, Fady Sayed Youssef … Samar M. Mouneir
    Studysummary This study found that ursolic acid at 50 mg/kg improved biochemical, hormonal, and ovarian histopathological markers in a rat model of PCOS, suggesting its potential as a therapeutic option.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 4

    1. Alternative Treatment of Polycystic Ovary Syndrome: Pre-Clinical and Clinical Basis for Using Plant-Based Drugs Frontiers in Endocrinology · 2024
    2. Signaling Pathways and Targeted Therapeutic Strategies for Polycystic Ovary Syndrome Frontiers in endocrinology · 2023
    3. Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance, and Obesity Clinica Chimica Acta · 2019
    4. Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline The Journal of Clinical Endocrinology and Metabolism · 2013